This week, ZenPharm, the Maltese joint venture with Canadian cannabis producer, Zenabis Global, received its Maltese licence to process cannabis for medicinal use and research purposes out of its Hal Far Industrial Estate premises.
Kurt Farrugia, CEO of Malta Enterprise – the national economic development agency that assisted the company to set up locally – considers this “an important milestone for Malta’s medical cannabis industry.”
“We are gaining momentum with the production of cannabis for medical use in Malta,” he wrote. “Zenabis – a Maltese joint venture and partner of Zenpharm, have received a licence for the production of medical cannabis in their facility in Hal Far, Malta.”
The CEO said that the issuing of the second licence for the production of cannabis for medical use shows that “Malta is becoming a centre of excellence in such an important emerging sector.”
“Those companies strive hard to achieve the Medicine’s Authority pharmaceutical standards. Now that they do, patients can rest assured that the Made in Malta product is top quality. A gold standard for the industry. This is indeed a proud moment.”
Through its licence, ZenPharm plans to ship around 500kg of cannabis out of Malta annually to EU countries, with the largest market being Germany.
Featured Image:
Kurt Farrugia / LinkedIn
GO-backed ‘unicorn’ Airalo ‘validates our strategy,’ says CEO Nikhil Patil
GO CEO pointed to the group’s early investment in eSIM leader Airalo a few years before it achieved unicorn status.
Valerie Spiteri appointed Head of Corporate at 242.group
Valerie Spiteri brings experience in operations, HR and corporate governance.
‘I used to use Blockchain.com to buy game items… now I’m CEO of its Malta hub’
Fiorentina D’Amore had opened her first crypto wallet with Blockchain.com, back when one bitcoin was only worth around €2.50.
KM Malta ‘committed to development of future aviation workforce’ – Chief People Officer
New MoU aims to strengthen MCAST students’ knowledge of the aviation sector.
